Silvana Martino

10.2k citations
72 papers · 4.6k indexed · h-index 31

Silvana Martino

71 papers receiving 4.4k citations

Peers

Silvana Martino
Comparison fields: 5 of 133
  • Cancer Research 1.2k
  • Oncology 1.6k
  • Immunology 1.2k
  • Pathology and Forensic Medicine 712
  • Immunology and Allergy 231
Replace Klaas Hoekman with:
Klaas Hoekman Netherlands
Marek Z. Wojtukiewicz Poland
Nicolaì Maass Germany
Katsumasa Kuroi Japan
N. J. O’Higgins Ireland
Mordechai Gutman Israel
G.H. Blijham Netherlands
Sachio Fushida Japan
Andrew J. Wagner United States
Madappa N. Kundranda United States
Silvana Martino relative to Klaas Hoekman Netherlands Klaas Hoekman's profile →
Citations per field
00.5×1.5×2.5×
Klaas Hoekman · 1×
Citations per year

Countries citing papers authored by Silvana Martino

Since Specialization
Citations

This map shows the geographic impact of Silvana Martino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvana Martino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvana Martino more than expected).

Fields of papers citing papers by Silvana Martino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvana Martino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvana Martino. The network helps show where Silvana Martino may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Silvana Martino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Silvana Martino Line = papers co-authored together Silvana Martino links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202113
2 201883
3 2011142
4 2009109
5 200912
6 20093
7 200829
8 2007137
9 2002158
10 19991
11 1999470
12
HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.
1998203
13 199744
14 199616
15 199383
16 199210
17 199217
18 19916
19 199112
20 199040

About Silvana Martino

Silvana Martino is a scholar working on Cancer Research, Oncology and Hematology, having authored 72 papers that have together received 4.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Cancer Treatment and Pharmacology (9 papers), HER2/EGFR in Cancer Research (8 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Global Cancer Incidence and Screening (4 papers), Immune Cell Function and Interaction (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.6k citations) and Immunology (1.2k citations). Silvana Martino has collaborated with scholars based in Italy, United States and Belarus. Frequent co-authors include C. Kent Osborne, Richard Elledge, James Waisman, Michael D. Lagios, Susan Groshen, Melvin J. Silverstein, Bernard S. Lewinsky, Parvis Gamagami, William J. Colburn and Stephanie Green.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026